Home > Insider Trading > Filing (0001140361-11-022920)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1296391	Tengion Inc	TNGN	Biological Products, (No Disgnostic Substances) (2836)	200214813

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341125	Richard Kuntz	C/O Tengion, Inc. 2900 Potshop Lane, Suite 100 East Norriton PA 19403		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock ($0.001 Par Value)	Acquisiton	2011-03-04	0	$0.00	0	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock ($0.001 Par Value)	Common Stock Warrant (right to buy)	Acquisiton	2011-03-04	0	$0.00	0	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	P	Indirect

Footnotes

On a Form 4 filed on April 18, 2011, Dr. Kuntz reported an indirect beneficial ownership in shares of common stock and warrants to acquire shares of common stock of Tengion, Inc. held by Medtronic, Inc. Dr. Kuntz is Medtronic, Inc.'s Senior Vice President and Chief Scientific, Clinical and Regulatory Officer. Pursuant to safe harbor set forth in Rule 16a-1(a)(2)(iii), Dr. Kuntz is not deemed to have a pecuniary interest in the securities held by Medtronic, Inc. and therefore was not required to file such Form 4 for that transaction. Therefore, such Form 4 was filed in error and should be considered withdrawn.